Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
priority review voucher
Pharma
Rocket nets $180M in priority review voucher sale
Rocket’s $180 million deal marks a slight cooling in the PRV market, which recently saw prices peak around $200 million.
Zoey Becker
Apr 28, 2026 11:16am
Fortress sells FDA voucher for $205M after Zycubo approval
Feb 23, 2026 10:15am
FDA’s rare pediatric voucher program revived by funding bill
Feb 4, 2026 3:12pm
JPM26: Jazz inks $200M priority review voucher sale
Jan 14, 2026 3:55pm
FDA 'proactively' awards J&J a national priority review voucher
Dec 15, 2025 12:33pm
House vote moves FDA's rare PRV program a step closer to revival
Dec 2, 2025 11:22am
